Abstract:Central MessageThe chimney technique is a key to ensuring successful mitral bioprosthesis implantation in patients with recurrent mitral regurgitation post-TAVI and TEER.See Commentary on page XXX. The chimney technique is a key to ensuring successful mitral bioprosthesis implantation in patients with recurrent mitral regurgitation post-TAVI and TEER. See Commentary on page XXX. The investigation was approved by the institutional review board (IRB-2024-068; approval date: May 6, 2024), and the patient gave written informed consent for publication. An 81-year-old man had recurrent exertional chest discomfort and dyspnea over a year, and orthopnea at night for a month. His symptoms included lower limb edema and palpitations. Echocardiography revealed moderate to severe aortic regurgitation, anterior mitral leaflet prolapse with severe regurgitation, and severe tricuspid regurgitation. An electrocardiogram confirmed atrial fibrillation. Considering his advanced age and European System for Cardiac Operative Risk Evaluation II score of 11.33%, a simultaneous transapical transcatheter aortic valve implantation (TA-TAVI) and TA transcatheter edge-to-edge repair (TA-TEER) was chosen. The surgery involved a 4-cm incision at the left chest's fifth intercostal space to access the apex, enabling the successful implantation of a 29-mm J-valve prosthesis (JieCheng Medical Technology Co) and 2 MVC-IIIf Valve Clamps (Hanyu Medical Technology). Postoperatively, the patient experienced symptom relief. Echocardiography confirmed optimal prosthetic aortic valve function showing a peak flow velocity of 1.7 meter per second and a peak gradient of 12 mm Hg, without any paravalvular leakage or regurgitation. The mitral valve demonstrated a peak flow velocity of 1.5 meter per second and a peak gradient of 7 mm Hg with mild regurgitation. Follow-up at 1, 3, and 6 months postoperation confirmed good valve function. Eight months after surgery, the patient experienced recurrent symptoms. Echocardiography showed the aortic valve functioning well, but revealed the left valve clamp had detached from the posterior mitral leaflet, a condition often referred to as single leaflet device attachment,1Maisano F. Franzen O. Baldus S. et al.Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.J Am Coll Cardiol. 2013; 62: 1052-1061Crossref PubMed Scopus (717) Google Scholar resulting in severe mitral regurgitation with a regurgitant area of 10 cm2 (Figure 1). Preoperative coronary angiography showed the swinging valve clamp (Video 1). A second operation employed the chimney technique to implant a skirted mitral bioprosthesis. The intraoperative exploration revealed a detached valve clamp and a torn original coaptation site (Figure 2, A and B). The native mitral valve and valve clamps were excised. A composite valve graft was assembled by a 30-mm artificial blood vessel (MAQUET Holding B.V. & Co) and a 27-mm mitral bioprosthesis (Medtronic) with running 4-0 polypropylene sutures (Figure 2, C). The graft margin was trimmed to a length of approximately 1 cm to avoid kinking, leaving 1 side slightly longer (Figure 2, D). Then, the composite valve graft was implanted at the mitral position (Video 2). Postoperative enhanced computed tomography (Video 3) and echocardiography validated the chimney technique's effectiveness, confirming optimal function of the new mitral bioprosthesis and avoiding interference from the TAVI valve stent.Figure 2A, The intraoperative investigation uncovered a detached valve clamp and a ruptured original coaptation site. B, The failed valve clamp removed from the mitral valve. C, A composite valve graft was assembled by a 30-mm artificial blood vessel and a 27-mm mitral bioprosthesis with running 4-0 polypropylene sutures. D, The length of the graft margin was tailored to approximately 1 cm with 1 side left slightly longer.View Large Image Figure ViewerDownload Hi-res image Download (PPT) The management of multiple valve diseases in elderly patients poses significant challenges, especially when compounded by advanced age and comorbid conditions. The Society of Thoracic Surgeons Registry data showed that the perioperative mortality for combined aortic and mitral valve operations (9.4%) is almost 3-fold higher than for isolated aortic valve replacements.2Rankin J.S. He X. O'Brien S.M. et al.The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery.Ann Thorac Surg. 2013; 95: 1484-1490Abstract Full Text Full Text PDF PubMed Google Scholar In this instance, an 81-year-old man with severe multivalvular disease underwent simultaneous TA-TAVI and TA-TEER. These minimally invasive procedures significantly reduced the physiological stress on the patient. This case underscores the increasing shift toward minimally invasive procedures for high-risk patients. In China, the National Medical Products Administration has approved only the J-valve for the treatment of aortic regurgitation via TAVI. Other TAVI products do not have approval for this indication. Consequently, at our center, we routinely use TA-TAVI with the J-valve for patients with aortic regurgitation, whereas TF-TAVI is employed for treating aortic stenosis. Furthermore, literature indicates that the J-valve achieves higher procedural success rates in treating aortic regurgitation compared with other transfemoral transcatheter aortic valve replacement devices.3Soong E.L. Ong Y.J. Ho J.S.Y. et al.Transcatheter aortic valve replacement for aortic regurgitation in Asians: TAVR for aortic regurgitation in Asians.AsiaIntervention. 2021; 7: 103-111Crossref PubMed Google Scholar This evidence supports our decision to use the TA route in this patient. The initial success of the TA-TAVI and TA-TEER in mitigating the patient's symptoms attests to the effectiveness of these techniques in addressing aortic and mitral regurgitations. The use of a 29-mm J-valve prosthesis and 2 MVC-IIIf Valve Clamps proved initially beneficial, achieving excellent postoperative outcomes with significant symptom alleviation and no paravalvular leakage, corroborated by follow-up echocardiography. These findings align with existing research, suggesting that TAVI and TEER can deliver favorable short-term results for elderly patients with complex valve diseases, substantially reducing the physiological stress associated with traditional open-heart surgery.4Baumgartner H. Iung B. Messika-Zeitoun D. Otto C.M. The year in cardiovascular medicine 2021: valvular heart disease.Eur Heart J. 2022; 43: 633-640Crossref Scopus (3) Google Scholar However, symptom recurrence 8 months postoperatively, marked by exertional chest discomfort and dyspnea, highlights the complexities and limitations of these procedures. The single leaflet device attachment and leaflet tear, resulting in severe regurgitation, emphasizes the need for durable device performance and highlights potential mechanical failures in transcatheter mitral valve repairs.1Maisano F. Franzen O. Baldus S. et al.Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.J Am Coll Cardiol. 2013; 62: 1052-1061Crossref PubMed Scopus (717) Google Scholar,5Glower D. Ailawadi G. Argenziano M. et al.EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure.J Thorac Cardiovasc Surg. 2012; 143: S60-S63Abstract Full Text Full Text PDF PubMed Scopus (75) Google Scholar This complication necessitated a secondary procedure using the chimney technique to implant a skirted bioprosthesis that was strategically chosen to prevent interference from the adjacent TAVI stent, showcasing a novel solution to complications from simultaneous transcatheter valve treatments. The successful application of the chimney technique is notable. This technique not only opens up the left ventricular outflow tract but also provides a durable solution to mitigate the risk of future valve failures. By establishing an artificial annulus distanced from the TAVI stent, the procedure ensures optimal functionality of the new mitral bioprosthesis while addressing the challenges posed by the proximity of the 2 devices. Especially for a patient in his eighth decade who has already undergone 2 heart surgeries within the past year, we specifically considered the potential influence of the TAVI stent below the aortic annulus on the newly implanted mitral bioprosthesis when devising the surgical plan. We aimed to minimize the risk of early degeneration of the mitral bioprosthesis caused by this factor because a third surgery within a short period might be difficult for such a patient to endure. The outcomes align with recent studies suggesting the chimney technique as a feasible option for mitral valve replacement in challenging anatomical conditions.6Yang M. Song L. Xiao Y. Tao L. Early and mid-term outcomes of using the chimney technique in redo mitral valve replacement in patients with a small mitral annulus.J Clin Med. 2024; 13: 270Crossref Scopus (0) Google Scholar,7Parachuri V.R. Tripathy A.K. Mallikarjuna J. Bio-chimney technique for narrow mitral annulus in adults.Ann Thorac Surg. 2019; 108: e65-e67Abstract Full Text Full Text PDF Scopus (1) Google Scholar This case highlights the necessity for continuous monitoring and potential future interventions for patients undergoing complex transcatheter valve repairs or replacements. It also accentuates the evolving landscape of valvular heart disease management, where ongoing surgical innovation is crucial to enhancing patient outcomes. The authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest. eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiI1NTg3YTA4YzRmMTg4NDczNGNiZWYyZGNiZDM1NjBiMyIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzI0MDAwNzg0fQ.izmg8DUdZhGiZaBAZy-PKOj2D8O_VSEynMJVLfhPvymxy1r10R_kZa4v6hkNP35c2lh-zY1Ojzwzft7ksLcgAx6Sn7WQSoZFeInuqCardXU6H2v6548sBFa4wCA6z1dVncHEpeQF7eIKi-kj-FENNZdQxQ5BqVEyj8QKugJTtJyUQST001ZW6eaAGe4HHPoZ78J614NxngRnlMCpvTqcaqBDu7AuNNmiAPBcxiMwKjGnZzH1pRP3qxbaUs8hQacOCJsqIFQtONZe38Bw9HIwrmUICvEriZiqDiEAwGJRQhzNRdXHXFFFS2B-E55SmlEq2oppg83JMqAJgnYJ2TNugQ Download .mp4 (1.5 MB) Help with .mp4 files Video 1Preoperative coronary angiography displayed the oscillating valve clamp moving in harmony with the cardiac cycle. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext. Download .jpg (.18 MB) Help with files Video 1Preoperative coronary angiography displayed the oscillating valve clamp moving in harmony with the cardiac cycle. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext.eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiIyNzdiZDZmMTc3YjE0Yzk1Yzk3NTE5NzNkMzM2OWVjYiIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzI0MDAwNzg0fQ.mSNoSrK80qRYXtzcRpJ6yE8WOAeGmZsotIJJ1JVbWcwu4MqnxMIkjFf6zZGrk8_OA6vrYmYEnxIhu0Wx6VKozeoYbTLlfDRyTakSK8EFi4aoE_4fc40VEqM1JeWMOF5XWD7RFZxzqEchdBTS_5ChYJnLfAPz-geFvOAk1dJXdtP3JPKnY_DXwf2kJM38B4d3h0jaJvSG3CFiHjb-iDqE-ec-fZ15cUqhd5L8iHJuZ__lKlzGw32mNgjG8GEgRadS7DuWTcBMMCBuOSqlc0F-6bIpbwW4-Zq1gq7rvxxP9cpsoJB6XhgcQruRoy_JTtNUUEWOUoXfV_O4zEsSASj-Xg Download .mp4 (1.28 MB) Help with .mp4 files Video 2A mitral bioprosthesis was implanted using the chimney technique. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext. Download .jpg (.44 MB) Help with files Video 2A mitral bioprosthesis was implanted using the chimney technique. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext.eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJkYWZiYzFlOTdlYTEzMjU2NjVmYzU5ZDI4NmQ1NjUyMSIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzI0MDAwNzg0fQ.XlDENt7F6RC7DYy3yJahK1vLxmIA84f_boeR2uSH5wSOVAda9kSWFtiv_3-AvP3TvcdkTB_u3UIUYMZBy5qhbbo6VLrO2uCb7MaD-4pAJabpaR7cu2ohli3yIx1JZqFPDvzAPBKxH--1U2r9IGSVCgfyb35B4JsCe5K2iJM10P1ZvIm_UhYUwahLUGhTV5G8y74shtrg6q0ZG_xTd1q17TtoIXpPCUbNurvJSP-csY0pj23NXYP3N2QZ9MHwdutR64avMqp-PhuCUe3jDXTe-otbOg86FUnO3OAt57WOe6zjLjbsJFKavEibA0CbWqb58rbjSi5bNhGDPEmQ7_dObg Download .mp4 (4.19 MB) Help with .mp4 files Video 3Postoperative enhanced computed tomography revealed the elevated site of the mitral bioprosthesis from the original mitral annulus, avoiding interference from the transcatheter aortic valve implantation valve stent. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext. Download .jpg (.14 MB) Help with files Video 3Postoperative enhanced computed tomography revealed the elevated site of the mitral bioprosthesis from the original mitral annulus, avoiding interference from the transcatheter aortic valve implantation valve stent. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext.

Abstract:The authors reported no conflicts of interest.The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.We read with interest the recent study by Färber and colleagues,1Färber G. Marx J. Scherag A. Saqer I. Diab M. Sponholz C. et al.Risk stratification for isolated tricuspid valve surgery assisted using the Model for End-Stage Liver Disease score.J Thorac Cardiovasc Surg. March 12, 2022; ([Epub ahead of print].)https://doi.org/10.1016/j.jtcvs.2021.11.102Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar which found that classic surgical risk stratification with the Society of Thoracic Surgeons or European System for Cardiac Operative Risk Evaluation II scores failed to predict perioperative mortality for isolated tricuspid valve surgery if there was evidence of severe liver dysfunction and the Model for End-Stage Liver Disease (MELD) scoring system might be useful to assist in risk stratification for these patients.As we know, patient selection is very critical for favorable outcomes after tricuspid valve surgery or intervention. The historical high mortality of isolated tricuspid valve surgery was partly due to late referral to surgery, resulting in right heart failure and end-organ damages such as liver and renal dysfunction. Thus, accurate risk stratification is useful to identify the high-risk subgroup. However, the paucity and heterogeneity of isolated tricuspid valve surgery led to difficulty in establishing a special risk stratification system.The MELD scoring system initially was developed for patients undergoing transjugular intrahepatic portosystemic shunt procedures2Malinchoc M. Kamath P.S. Gordon F.D. Peine C.J. Rank J. ter Borg P.C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.Hepatology. 2000; 31: 864-871Crossref PubMed Scopus (2069) Google Scholar and further for patients with end-stage liver disease.3Kamath P.S. Wiesner R.H. Malinchoc M. Kremers W. Therneau T.M. Kosberg C.L. et al.A model to predict survival in patients with end-stage liver disease.Hepatology. 2001; 33: 464-470Crossref PubMed Scopus (3668) Google Scholar,4Wiesner R. Edwards E. Freeman R. Harper A. Kim R. Kamath P. et al.Model for end-stage liver disease (MELD) and allocation of donor livers.Gastroenterology. 2003; 124: 91-96Abstract Full Text Full Text PDF PubMed Scopus (1937) Google Scholar Subsequently, Suman and colleagues5Suman A. Barnes D.S. Zein N.N. Levinthal G.N. Connor J.T. Carey W.D. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores.Clin Gastroenterol Hepatol. 2004; 2: 719-723Abstract Full Text Full Text PDF PubMed Scopus (206) Google Scholar found that MELD score was significantly associated with hepatic decompensation and mortality after cardiac surgery using cardiopulmonary bypass in patients with cirrhosis. Ailawadi and colleagues6Ailawadi G. Lapar D.J. Swenson B.R. Siefert S.A. Lau C. Kern J.A. et al.Model for end-stage liver disease predicts mortality for tricuspid valve surgery.Ann Thorac Surg. 2009; 87: 1460-1467Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar used the MELD score to predict mortality for tricuspid valve surgery, although 85.7% of the patients in their study had various concomitant surgeries.Färber and colleagues1Färber G. Marx J. Scherag A. Saqer I. Diab M. Sponholz C. et al.Risk stratification for isolated tricuspid valve surgery assisted using the Model for End-Stage Liver Disease score.J Thorac Cardiovasc Surg. March 12, 2022; ([Epub ahead of print].)https://doi.org/10.1016/j.jtcvs.2021.11.102Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar first used the MELD score for isolated tricuspid valve surgery in a relatively large cohort. However, both their and our studies suggested that the etiology of isolated tricuspid valve surgery was highly heterogenous.1Färber G. Marx J. Scherag A. Saqer I. Diab M. Sponholz C. et al.Risk stratification for isolated tricuspid valve surgery assisted using the Model for End-Stage Liver Disease score.J Thorac Cardiovasc Surg. March 12, 2022; ([Epub ahead of print].)https://doi.org/10.1016/j.jtcvs.2021.11.102Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar,7Chen J. Abudupataer M. Hu K. Maimaiti A. Lu S. Wei L. et al.Risk factors associated with perioperative morbidity and mortality following isolated tricuspid valve replacement.J Surg Res. 2018; 221: 224-231Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar Notably, 1 parameter of the MELD score is international normalized ration (INR).3Kamath P.S. Wiesner R.H. Malinchoc M. Kremers W. Therneau T.M. Kosberg C.L. et al.A model to predict survival in patients with end-stage liver disease.Hepatology. 2001; 33: 464-470Crossref PubMed Scopus (3668) Google Scholar We speculated that part of patients in their study may receive warfarin for left-sided mechanic valve replacement or chronic atrial fibrillation.8Chen J. Hu K. Ma W. Lv M. Shi Y. Liu J. et al.Isolated reoperation for tricuspid regurgitation after left-sided valve surgery: technique evolution.Eur J Cardiothorac Surg. 2020; 57: 142-150Crossref PubMed Scopus (19) Google Scholar,9Chen J. Ma W. Ming Y. Wang W. Liu S. Yang Y. et al.Minimally invasive valve replacement for late tricuspid regurgitation after left-sided valve surgery.Ann Thorac Surg. 2021; 111: e381-e383Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar Would this increased INR due to warfarin administration influence the MELD score and further influence the accuracy of risk prediction for this subgroup? Actually, the simplified MELD score has been reported by Tsuda and colleagues.10Tsuda K. Koide M. Kunii Y. Watanabe K. Miyairi S. Ohashi Y. et al.Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery.Interact Cardiovasc Thorac Surg. 2013; 16: 630-635Crossref PubMed Scopus (18) Google Scholar They suggested to remove the INR parameter from the formula to predict mortality for tricuspid valve surgery, although 93.6% of patients in their study also had various concomitant surgery. In our previous study, we found that higher simplified MELD score was an independent risk factor for composite adverse outcomes rather than mortality.8Chen J. Hu K. Ma W. Lv M. Shi Y. Liu J. et al.Isolated reoperation for tricuspid regurgitation after left-sided valve surgery: technique evolution.Eur J Cardiothorac Surg. 2020; 57: 142-150Crossref PubMed Scopus (19) Google Scholar Thus, the simplified MELD score has also not been widely validated for predicting mortality of isolated tricuspid valve surgery.The ideal risk stratification for isolated tricuspid valve surgery is still on the way. Many efforts have been made in this field. A simple clinical risk score based on the Society of Thoracic Surgeons database was established to predict mortality and major morbidity after isolated tricuspid valve surgery.11LaPar D.J. Likosky D.S. Zhang M. Theurer P. Edwin Fonner C. Kern J.A. et al.Development of a risk prediction model and clinical risk score for isolated tricuspid valve surgery.Ann Thorac Surg. 2018; 106: 129-136Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar That clinical risk score enrolled 9 parameters, including age, sex, stroke, hemodialysis, chronic lung disease, ejection fraction, New York Heart Association functional class, reoperation, and status. Recently, the TRI-SCORE was reported as a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.12Dreyfus J. Audureau E. Bohbot Y. Coisne A. Lavie-Badie Y. Bouchery M. et al.TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.Eur Heart J. 2022; 43: 654-662Crossref PubMed Scopus (25) Google Scholar It ranged from 0 to 12 points and included 8 parameters: age ≥70 years, New York Heart Association functional class III or IV, right-sided heart failure signs, daily dosage of furosemide ≥125 mg, glomerular filtration rate <30 mL/min, elevated bilirubin, left ventricular ejection fraction <60%, and moderate/severe right ventricular dysfunction. However, these scoring systems were somewhat complex and some parameters were subjective. With the development of transcatheter tricuspid valve repair or replacement, more hemodynamic data of isolated tricuspid regurgitation and right heart failure were obtained by right heart catheterization.13Unterhuber M. Kresoja K.P. Besler C. Rommel K.-P. Orban M. von Roeder M. et al.Cardiac output states in patients with severe functional tricuspid regurgitation: impact on treatment success and prognosis.Eur J Heart Fail. 2021; 23: 1784-1794Crossref PubMed Scopus (6) Google Scholar,14Stocker T.J. Hertell H. Orban M. Braun D. Rommel K.-P. Ruf T. et al.Cardiopulmonary hemodynamic profile predicts mortality after transcatheter tricuspid valve repair in chronic heart failure.JACC Cardiovasc Interv. 2021; 14: 29-38Crossref PubMed Scopus (27) Google Scholar Some effects were also made to investigate special molecular mechanism of right ventricular failure.15Tzimas C. Rau C.D. Buergisser P.E. Jean-Louis Jr., G. Lee K. Chukwuneke J. et al.WIPI1 is a conserved mediator of right ventricular failure.JCI Insight. 2019; 5PubMed Google Scholar In the future, the risk scoring system may integrate multidimensional parameters, including symptomatic, echocardiographic, hemodynamic, and molecular variables, to accurately predict the risk of isolated tricuspid valve surgery and intervention. The authors reported no conflicts of interest.The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest. The authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest. We read with interest the recent study by Färber and colleagues,1Färber G. Marx J. Scherag A. Saqer I. Diab M. Sponholz C. et al.Risk stratification for isolated tricuspid valve surgery assisted using the Model for End-Stage Liver Disease score.J Thorac Cardiovasc Surg. March 12, 2022; ([Epub ahead of print].)https://doi.org/10.1016/j.jtcvs.2021.11.102Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar which found that classic surgical risk stratification with the Society of Thoracic Surgeons or European System for Cardiac Operative Risk Evaluation II scores failed to predict perioperative mortality for isolated tricuspid valve surgery if there was evidence of severe liver dysfunction and the Model for End-Stage Liver Disease (MELD) scoring system might be useful to assist in risk stratification for these patients. As we know, patient selection is very critical for favorable outcomes after tricuspid valve surgery or intervention. The historical high mortality of isolated tricuspid valve surgery was partly due to late referral to surgery, resulting in right heart failure and end-organ damages such as liver and renal dysfunction. Thus, accurate risk stratification is useful to identify the high-risk subgroup. However, the paucity and heterogeneity of isolated tricuspid valve surgery led to difficulty in establishing a special risk stratification system. The MELD scoring system initially was developed for patients undergoing transjugular intrahepatic portosystemic shunt procedures2Malinchoc M. Kamath P.S. Gordon F.D. Peine C.J. Rank J. ter Borg P.C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.Hepatology. 2000; 31: 864-871Crossref PubMed Scopus (2069) Google Scholar and further for patients with end-stage liver disease.3Kamath P.S. Wiesner R.H. Malinchoc M. Kremers W. Therneau T.M. Kosberg C.L. et al.A model to predict survival in patients with end-stage liver disease.Hepatology. 2001; 33: 464-470Crossref PubMed Scopus (3668) Google Scholar,4Wiesner R. Edwards E. Freeman R. Harper A. Kim R. Kamath P. et al.Model for end-stage liver disease (MELD) and allocation of donor livers.Gastroenterology. 2003; 124: 91-96Abstract Full Text Full Text PDF PubMed Scopus (1937) Google Scholar Subsequently, Suman and colleagues5Suman A. Barnes D.S. Zein N.N. Levinthal G.N. Connor J.T. Carey W.D. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores.Clin Gastroenterol Hepatol. 2004; 2: 719-723Abstract Full Text Full Text PDF PubMed Scopus (206) Google Scholar found that MELD score was significantly associated with hepatic decompensation and mortality after cardiac surgery using cardiopulmonary bypass in patients with cirrhosis. Ailawadi and colleagues6Ailawadi G. Lapar D.J. Swenson B.R. Siefert S.A. Lau C. Kern J.A. et al.Model for end-stage liver disease predicts mortality for tricuspid valve surgery.Ann Thorac Surg. 2009; 87: 1460-1467Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar used the MELD score to predict mortality for tricuspid valve surgery, although 85.7% of the patients in their study had various concomitant surgeries. Färber and colleagues1Färber G. Marx J. Scherag A. Saqer I. Diab M. Sponholz C. et al.Risk stratification for isolated tricuspid valve surgery assisted using the Model for End-Stage Liver Disease score.J Thorac Cardiovasc Surg. March 12, 2022; ([Epub ahead of print].)https://doi.org/10.1016/j.jtcvs.2021.11.102Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar first used the MELD score for isolated tricuspid valve surgery in a relatively large cohort. However, both their and our studies suggested that the etiology of isolated tricuspid valve surgery was highly heterogenous.1Färber G. Marx J. Scherag A. Saqer I. Diab M. Sponholz C. et al.Risk stratification for isolated tricuspid valve surgery assisted using the Model for End-Stage Liver Disease score.J Thorac Cardiovasc Surg. March 12, 2022; ([Epub ahead of print].)https://doi.org/10.1016/j.jtcvs.2021.11.102Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar,7Chen J. Abudupataer M. Hu K. Maimaiti A. Lu S. Wei L. et al.Risk factors associated with perioperative morbidity and mortality following isolated tricuspid valve replacement.J Surg Res. 2018; 221: 224-231Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar Notably, 1 parameter of the MELD score is international normalized ration (INR).3Kamath P.S. Wiesner R.H. Malinchoc M. Kremers W. Therneau T.M. Kosberg C.L. et al.A model to predict survival in patients with end-stage liver disease.Hepatology. 2001; 33: 464-470Crossref PubMed Scopus (3668) Google Scholar We speculated that part of patients in their study may receive warfarin for left-sided mechanic valve replacement or chronic atrial fibrillation.8Chen J. Hu K. Ma W. Lv M. Shi Y. Liu J. et al.Isolated reoperation for tricuspid regurgitation after left-sided valve surgery: technique evolution.Eur J Cardiothorac Surg. 2020; 57: 142-150Crossref PubMed Scopus (19) Google Scholar,9Chen J. Ma W. Ming Y. Wang W. Liu S. Yang Y. et al.Minimally invasive valve replacement for late tricuspid regurgitation after left-sided valve surgery.Ann Thorac Surg. 2021; 111: e381-e383Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar Would this increased INR due to warfarin administration influence the MELD score and further influence the accuracy of risk prediction for this subgroup? Actually, the simplified MELD score has been reported by Tsuda and colleagues.10Tsuda K. Koide M. Kunii Y. Watanabe K. Miyairi S. Ohashi Y. et al.Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery.Interact Cardiovasc Thorac Surg. 2013; 16: 630-635Crossref PubMed Scopus (18) Google Scholar They suggested to remove the INR parameter from the formula to predict mortality for tricuspid valve surgery, although 93.6% of patients in their study also had various concomitant surgery. In our previous study, we found that higher simplified MELD score was an independent risk factor for composite adverse outcomes rather than mortality.8Chen J. Hu K. Ma W. Lv M. Shi Y. Liu J. et al.Isolated reoperation for tricuspid regurgitation after left-sided valve surgery: technique evolution.Eur J Cardiothorac Surg. 2020; 57: 142-150Crossref PubMed Scopus (19) Google Scholar Thus, the simplified MELD score has also not been widely validated for predicting mortality of isolated tricuspid valve surgery. The ideal risk stratification for isolated tricuspid valve surgery is still on the way. Many efforts have been made in this field. A simple clinical risk score based on the Society of Thoracic Surgeons database was established to predict mortality and major morbidity after isolated tricuspid valve surgery.11LaPar D.J. Likosky D.S. Zhang M. Theurer P. Edwin Fonner C. Kern J.A. et al.Development of a risk prediction model and clinical risk score for isolated tricuspid valve surgery.Ann Thorac Surg. 2018; 106: 129-136Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar That clinical risk score enrolled 9 parameters, including age, sex, stroke, hemodialysis, chronic lung disease, ejection fraction, New York Heart Association functional class, reoperation, and status. Recently, the TRI-SCORE was reported as a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.12Dreyfus J. Audureau E. Bohbot Y. Coisne A. Lavie-Badie Y. Bouchery M. et al.TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.Eur Heart J. 2022; 43: 654-662Crossref PubMed Scopus (25) Google Scholar It ranged from 0 to 12 points and included 8 parameters: age ≥70 years, New York Heart Association functional class III or IV, right-sided heart failure signs, daily dosage of furosemide ≥125 mg, glomerular filtration rate <30 mL/min, elevated bilirubin, left ventricular ejection fraction <60%, and moderate/severe right ventricular dysfunction. However, these scoring systems were somewhat complex and some parameters were subjective. With the development of transcatheter tricuspid valve repair or replacement, more hemodynamic data of isolated tricuspid regurgitation and right heart failure were obtained by right heart catheterization.13Unterhuber M. Kresoja K.P. Besler C. Rommel K.-P. Orban M. von Roeder M. et al.Cardiac output states in patients with severe functional tricuspid regurgitation: impact on treatment success and prognosis.Eur J Heart Fail. 2021; 23: 1784-1794Crossref PubMed Scopus (6) Google Scholar,14Stocker T.J. Hertell H. Orban M. Braun D. Rommel K.-P. Ruf T. et al.Cardiopulmonary hemodynamic profile predicts mortality after transcatheter tricuspid valve repair in chronic heart failure.JACC Cardiovasc Interv. 2021; 14: 29-38Crossref PubMed Scopus (27) Google Scholar Some effects were also made to investigate special molecular mechanism of right ventricular failure.15Tzimas C. Rau C.D. Buergisser P.E. Jean-Louis Jr., G. Lee K. Chukwuneke J. et al.WIPI1 is a conserved mediator of right ventricular failure.JCI Insight. 2019; 5PubMed Google Scholar In the future, the risk scoring system may integrate multidimensional parameters, including symptomatic, echocardiographic, hemodynamic, and molecular variables, to accurately predict the risk of isolated tricuspid valve surgery and intervention. Risk stratification for isolated tricuspid valve surgery assisted using the Model for End-Stage Liver Disease scoreThe Journal of Thoracic and Cardiovascular SurgeryPreviewIsolated tricuspid valve surgery is perceived as high-risk. This perception is nurtured by patients who often present with substantial liver dysfunction, which is inappropriately reflected in current surgical risk scores (eg, the Society of Thoracic Surgeons [STS] score has no specific tricuspid model). The Model for End-Stage Liver Disease (MELD) has was developed as a measure for the severity of liver dysfunction. We report scores and outcomes for our patient population. Full-Text PDF Reply from authors: Why improve high-risk prediction if early surgery is low risk?JTCVS OpenVol. 11PreviewWe wish to thank Chen and colleauges1 for their appreciative comment regarding our recent manuscript on the model for end-stage liver disease (MELD) score in isolated tricuspid surgery. We fully agree with the general notion that we need better and simpler scores to assess preoperative risk, such as the TRI-SCORE or the simple clinical risk score. While these 2 scores seem to have been assessed in parallel to our investigation, they are still more complex (requiring echocardiographic parameters for the right heart, which are still controversial, TRI-SCORE) or do not include any liver-related parameters (clinical risk score). Full-Text PDF Open Access

Prosthesis Choice for Tricuspid Valve Replacement in the Era of Transcatheter Valve-in-valve Technique

Outcomes after implantation of right-sided mechanical valve prostheses in congenital heart disease

Tricuspid Valve Replacement: An Analysis of Risk Factors and Outcomes

Long-Term Outcomes of Tricuspid Valve Replacement With Mechanical Versus Tissue Valves: Meta-Analysis of Reconstructed Time-to-Event Data

When should a mechanical tricuspid valve replacement be considered?

Mechanical or biological prosthesis for aortic valve replacement in patients aged 45 to 74 years

Technical Details of Aortic Valve Replacement using Carpentier–Edwards PERIMOUNT Magna Ease Aortic Bioprosthesis in a Sexagenarian Patient with Severe Calcific Aortic Stenosis: A Video Presentation

Isolated Tricuspid Valve Surgery for Functional Tricuspid Regurgitation

Which is the best prosthesis in an isolated or combined tricuspid valve replacement?

Long-term outcomes of isolated mechanical versus bioprosthetic mitral valve replacement in different age groups of propensity-matched patients

Tissue versus mechanical mitral valve replacement in patients aged 50-70: a propensity-matched analysis

Age-Based Outcomes After Surgical Aortic Valve Replacement With Bioprosthetic Versus Mechanical Valves

Comparison of outcomes between transcatheter tricuspid valve repair and surgical tricuspid valve replacement or repair in patients with tricuspid insufficiency

Long-term outcomes following aortic valve replacement in bioprosthetic vs mechanical valves

"Chimney Technique" for Recurrent Mitral Regurgitation Post-transapical Transcatheter Aortic Valve Implantation and Transcatheter Edge-to-edge Repair

Risk Stratification for Isolated Tricuspid Valve Surgery: Still on the Way

Clinical analysis on tricuspid valve replacement for secondary tricuspid regurgitation late after left-sided valve surgery

Tricuspid Valve Replacement in the Treatment of Severe Tricuspid Valve Disease: a Report of 27 Cases

Transcatheter Tricuspid Valve-in-valve Implantation for Degenerated Surgical Bioprosthesis.

Isolated Reoperation for Tricuspid Regurgitation after Left-Sided Valve Surgery: Technique Evolution

Bioprosthetic tricuspid valve replacement for tricuspid valve endocarditis secondary to infected endocardial pacemaker leads